428PD - Damaging germline variants in TSC2 are frequently found among nonsyndromic patients with gastroenteropancreatic (GEP) neuroendocrine tumors (NETs)

Autor: Linck, R.D.M., Asprino, P.F., Freitas, F.P., Koyama, F.C., Galante, P.A.F., Riechelmann, R., Reis, L.F.L., Costa, F.P., Hoff, P.M., Camargo, A.A., Sabbaga, J.
Zdroj: In Annals of Oncology 1 October 2016 27 Supplement 6:vi140-vi140
Databáze: ScienceDirect